Tryptophan degradation and serum neopterin concentrations in intensive care unit patients

Toxicology Mechanisms and Methods

Volumn 21, Issue 3, 2011, Pages 231-235

  Girgin, Gozde ^a   Sahin, Tevfik Tolga ^b   Fuchs, Dietmar ^c   Yuksel, Osman ^b   Kurukahvecioglu, Osman ^b   Sare, Mustafa ^b   Baydar, Terken ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Biomarker; kynurenine; neopterin; tryptophan

Indexed keywords

BIOLOGICAL MARKER; KYNURENINE; NEOPTERIN; TRYPTOPHAN;

ADULT; APACHE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DEGRADATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; APACHE; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNE SYSTEM; INTENSIVE CARE; KYNURENINE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPTERIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRYPTOPHAN;

EID: 79951910358     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2010.545960     Document Type: Article

References (32)

1. Adamik B, Küler-Kielb J, Golebiowska B, Gamian A, Küler A. 2000. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 26:1259-1267.
2. Baydar T, Yuksel O, Sahin TT, Dikmen K, Girgin G, Sipahi H, Kurukahvecioglu O, Bostanci H, Sare M. 2009. Neopterin as a prognostic biomarker in intensive care unit patients. J Crit Care 24:318-321.
3. Chen Y, Guillemin GJ. 2009. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1-19.
4. Cinel I, Dellinger RP. 2007. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20:345-352.
5. Cotran RS, Kumar V, Collins SL, eds. 1999. Robbins Pathologic Basis of Disease, 6th ed. Philadelphia: WB Saunders Co.,pp. 113-138
6. Fuchs D, Weiss G, Reibnegger G, Wachter H. 1992. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29:307-341.
7. Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W. 1998. Monocyte function before and after surgical trauma. Dig Surg 15:102-104.
8. Hensler T, Sauerland S, Lefering R, Nagelschmidt M, Bouillon B, Andermahr J, Neugebauer EA. 2003. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20:420-426.
9. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310-316.
10. Huttunen R, Syrj?en J, Aittoniemi J, Oja SS, Raitala A, Laine J, Pertovaara M, Vuento R, Huhtala H, Hurme M. 2010. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock 33:149-154.
11. Ip M, Rainer TH, Lee N, Chan C, Chau SS, Leung W, Leung MF, Tam TK, Antonio GE, Lui G, Lau TK, Hui DS, Fuchs D, Renneberg R, Chan PK. 2007. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 59:131-136.
12. King NJ, Thomas SR. 2007. Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 39:2167-2172.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: a severity of disease classification system. Crit Care Med 13:818-829.
14. Laich A, Neurauter G, Widner B, Fuchs D. 2002. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 48:579-581.
15. Lin E, Calvano SE, Lowry SF. 2005. Systemic response to injury and metabolic support. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE, eds. Schwartz's Principles of Surgery, 8th ed. New York: McGraw Hill, pp. 4.
16. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. 1999. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3:45-50.
17. Mitaka C. 2005. Clinical laboratory differentiation of infectious versus noninfectious systemic inflammatory response syndrome. Clin Chim Acta 351:17-29.
18. Munn DH, Mellor AL. 2007. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147-1154.
19. Pellegrin K, Neurauter G, Wirleitner B, Fleming AW, Peterson VM, Fuchs D. 2005. Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 23:209-215.
20. Ploder M, Spitter A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D. 2009a. Accelerated tryptophan degradation in trauma and sepsis patients is related to pro-inflammatory response and to the diminished in vitro response of monocytes. Pteridines 20:54-61.
21. Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D. 2009b. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. Clin Sci 116:593-598.
22. Ruokonen E, Ilkka L, Niskanen M, Takala J. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46:398-404.
23. Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D. 2006. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82-90.
24. Strohmaier W, Redl H, Schlag G, Inthorn D. 1987. d-Erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 15:757-760.
25. Tattevin P, Monnier D, Tribut O, Dulong J, Bescher N, Mourcin F, Uhel F, Le Tulzo Y, Tarte K. 2010. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. J Infect Dis 201:956-966.
26. Taylor MW, Feng GS. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-2522.
27. Toussaint S, Gerlach H. 2009. Activated protein C for sepsis. N Engl J Med 361:2646-2652.
28. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. 1989. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe-Seyler 370:1063-1069.
29. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424-2426.
30. Widner B, Wirleitner B, Baier-Bitterlich G, Weiss G, Fuchs D. 2000. Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch Immunol Ther Exp (Warsz) 48:251-258.
31. Wirleitner B, Reider D, Ebner S, B?k G, Widner B, Jaeger M, Schennach H, Romani N, Fuchs D. 2002. Monocyte-derived dendritic cells release neopterin. J Leukoc Biol 72:1148-1153.
32. Yao YM, Yu Y, Wang YP, Tian HM, Sheng ZY. 1996. Elevated serum neopterin level: its relation to endotoxemia and sepsis in patients with major burns. Eur J Clin Invest 26:224-230.